Chaudhry Hamzah E, Khan Somieya, Jamil Sidra, Shaik Tanveer Ahamad, Ehsan Ullah Saad, Bseiso Anan, Sathish Meenakshi, Saleem Faraz, Ghaffari Muhammad Abu Zar
Medical School, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Accident and Emergency, Glan Clwyd Hospital, Rhyl, GBR.
Cureus. 2022 Oct 20;14(10):e30498. doi: 10.7759/cureus.30498. eCollection 2022 Oct.
The use of antimalarial drugs for prophylaxis is a widespread practice while traveling to underdeveloped nations, particularly those with a high malaria prevalence. Chloroquine is still one of the most commonly recommended antimalarials, either alone or in combination with others, for prophylaxis. However, its increased use over the past few decades has been associated with many adverse effects, including headaches, dizziness, vomiting, and diarrhea, as well as neuropsychiatric symptoms such as psychosis. Here, we discuss the case of a 30-year-old Asian man who, after starting a 500-milligram (mg) prophylactic dosage of chloroquine per week, developed psychotic symptoms. This case highlights the need to use chloroquine and other antimalarials with care, especially when beginning as a prophylactic measure with the lowest suggested dosage.
前往不发达国家旅行时,使用抗疟药物进行预防是一种普遍做法,尤其是在疟疾高发的国家。氯喹仍然是最常被推荐用于预防的抗疟药物之一,可单独使用或与其他药物联合使用。然而,在过去几十年中,其使用增加与许多不良反应相关,包括头痛、头晕、呕吐和腹泻,以及诸如精神病等神经精神症状。在此,我们讨论一名30岁亚洲男性的病例,该患者在开始每周服用500毫克氯喹预防剂量后出现了精神病症状。该病例凸显了谨慎使用氯喹和其他抗疟药物的必要性,尤其是在开始以最低建议剂量作为预防措施时。